NewGenIvf Group Limited (NIVF) is having a rougher Friday than its shareholders would like. After a wild Thursday where the stock surged more than 50%, the shares are now giving back some of those gains as traders take profits.
The Thursday rally didn't come out of nowhere. The company filed a press release with the SEC announcing a strategic partnership and investment agreement that got investors excited. The catalyst: a $2 million investment into K25.ai, an AI-powered watch-to-predict live-streaming platform led by tech veteran Andy Cheung. The deal values K25.ai at a $100 million pre-money valuation.
"This strategic investment provides NewGenIvf with exposure to the convergence of AI, live streaming, creator monetization and prediction-based information markets," said Alfred Siu Wing Fung, Founder, Chairman and CEO of NewGenIvf.
The transaction also includes an exclusive agency partnership in certain Asia-Pacific markets (excluding Mainland China and Hong Kong), and NewGenIvf has an option to increase its total investment up to $10 million, subject to definitive agreements.
But here's the thing: one good day doesn't fix a broken trend. NIVF is still deep in a downtrend. It's trading 32.4% below its 20-day moving average, 48.5% below its 50-day, 72.7% below its 100-day, and a staggering 97.6% below its 200-day SMA. The stock's 52-week range tells the story: it's at $0.94, compared to a low of $0.73 and a high of $613. Yes, $613. That's not a typo.
For traders watching the charts, the key levels are clear. Resistance sits at $1.35, which lines up with the 20-day SMA — a common spot where downtrends reject bounces. Support is at $0.73, the 52-week low zone.
At the time of publication Friday, NewGenIvf shares were down 17.86% at $0.92. The stock is trading near its 52-week low of $0.72, according to market data.
So while the AI news gave the stock a jolt, the underlying trend suggests this might be a blip rather than a turnaround. For now, traders are taking their profits and stepping back.
